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ANGIOARCHITECTURE OF UTERINE CERVICAL LEIOMYOMATA 
— A SEM STUDY
Abstract: A i m: The main goal of this study was assessment of vascular structure of cervical uterine 
leiomyomata.
M a t e r i a l s  a n d  M e t h o d s: The study was carried out on ten human uteri collected upon autop-
sy. Vessels were injected with synthetic resin, next corroded and coated with gold, finally observed 
using scanning electron microscope.
R e s u l t s: Most of cervical fibroids were observed in the middle third of the wall of cervix. They were 
surrounded by relatively dense ‘vascular capsule’. consisted of flattened vein, arterioles and capillaries. 
C o n c l u s i o n s: Structure of cervical uterine leiomyomata was similar to those observed in initial 
stage of growth of myometrial fibroids.
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INTRODUCTION
Leiomyomata develop from transformation of smooth muscle cell and/or connec-
tive tissue components. Molecules that initiate transformation and regulate tumor 
growth remain unknown. Uterine leiomyomata, the most common benign tumours 
of the female internal genital system are traditionally classified into: intramural, 
subserous, or submucous [1]. Following the regulation of the European Society 
of Hysteroscopy the submucous fibroids are divided depending on the protrusion 
within the uterine cavity, into types 0, I and II. Growth factors are usually cer-
tain molecules that influence growth of cells, their differentiation, growth of new 
vessels, cellular hypertrophy. Among key growth factors identified in leiomyomata 
are members of epidermal growth factor family, platelet derived growth factor, 
vascular endothelial growth factor, fibroblast growth factor, transforming growth 
factor-beta [2], adrenomedullin [3], insulin-like growth factor, substance P [4], 
heparin-binding growth factor [5]. Blood supply of normal human uterine cervix 
was a subject of several studies, using corrosion casting and scanning electron 
microscopy (SEM) [6]. Most of the reports on leiomyoma blood supply are quali-
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tative and consider blood supply within the uterine corpus [7–16]. The purpose 
for this study was to evaluate the vascular structure of the uterine leiomyomata 
of less common location, within the uterine cervix, using the microcorrosion 
technique SEM [17].
MATERIAL AND METHODS
Ten uteri containing intracervical fibroids were obtained upon autopsy of wo-
men aged 25–56 years, deceased due to causes not related to disorders of the 
reproductive system. The material was collected 6–24 h after death. Each uterus 
together with ovaries and cervical portion of the vagina was removed in such 
a way that relatively long fragments of uterine and ovarian vessels (arteries and 
veins) were retained.
Immediately after removal, all uteri were perfused via the afferent arteries with 
prewarmed (37oC), heparinized saline (12.5 IU/ml heparin; Polfa, Poland, conta-
ining 3% dextrane (70kDa) and 0.025% lidocaine (Lignocaine; Polfa, Poland), un-
til the fluid outflowing via the veins was completely transparent (~5 min). Next 
perfusion was continued using a solution of 0.66% paraformaldehyde/0.08% glu-
taraldehyde (Sigma, Germany) in 0.1 mol/l cacodylate buffer, pH 7.4 supplemented 
with 0.2% lidocaine. Finally, the vascular system was injected with 60–80 ml of 
Mercox CL-2R resin (Vilene Comp. Ltd. Japan) containing 0.0625 mg/ml methyl 
acrylate polymerization initiator (Vilene Comp. Ltd.) Japan and the uteri were left 
in a warm water bath (56oC) for several hours to allow polymerization and tem-
pering of the resin.
When the polymerization was completed, the uterine tissues were macerated 
for 5–6 days by repeated baths in 10% potassium hydroxide at 37oC followed by 
washing with warm (50–55oC) running tap water. The obtained vascular casts 
were washed for the next 4–5 days in multiple changes of distilled water under 
mild vacuum conditions, cleaned in 5% trichloroacetic acid for 1–2 days, washed 
again in distilled water for 2–3 days and freeze-dried in a lyophilizer (Liovag G2; 
Aqua Fina, Germany).
The freeze-dried casts were examined macroscopically, gently dissected [18] to 
expose the vasculature of myomata and stored in an exiccator containing pho-
sphorus pentoxide until the microscopic examination. They were then mounted 
onto copper plates using colloidal silver and ‘conductive bridges’ and coated with 
gold. The casts were examined using a JEOL SEM 35-CF (Jeol, France) scanning 
electron microscope at 20–25 kV. The study was approved by Ethical Committee 
of Jagiellonian University (KBET/121/8/2007).
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RESULTS
Uterine cervix consists of large amounts of dense collections of connective tissue 
which is mostly consisting of an extracellular matrix. This matrix may be a source 
of large quantities of different vascular growth factors, what may promote angio-
genesis in the cervical uterine fibroids. Most of observed tumours were however 
avascular. They were found in the lateral third of the cervical wall. It seems that 
their development is based mostly on the incorporation of the maternal vascular 
bed, while their own vessels were not fully formed yet. We did not observe large 
vessels running through the substance of the leiomyomata, as seen within the 
intramural fibroids. The peripheral vascular capsule [19–22] was also less dense 
as seen within the previously described tumours.
Uterine cervix differs structurally from the fundus and corpus of the uterus. 
Its mucosa is not exfoliated during menstruation. The muscular layer is signifi-
cantly thinner than this in the corpus and contains relatively high quantities of 
the connective tissue elements. Such structure and quite permanent anatomical 
condition cause that vascular network in this area is relatively regular. Rich 
amounts of connective tissue and less amount of muscular fibers are causative 
factors of less common frequency of intracervical fibroids, comparing to the leio-
myomata of the corpus.
The tumours seen in the cervix were predominantly visible in the muscular 
layer of this region, quite a large distance from the cervical canal, approximately 
13–27 mm away from its long axis (Fig. 1). In the sagittal sections the intracervical 
fibroids were seen as the cavities, characterized by a loose peripheral “vascular 
capsule” in comparison to the dense capsule of intramural fibroids (Fig. 2, Fig. 3). 
Generally at first sight the intracervical fibroids were characterized by an absence 
of the “vascular capsule” (Fig. 4) [23–26]. The vessels inside the fibroids were 
absent what could be a result of their true absence, due to the primary stage of 
their development or an artifact due to poor injection. In the outer surface of such 
fibroids one could observe large vessels traversing the surface. Large vessels were 
surrounded by empty regions which might have been the result of condensation 
of perivascular connective tissue, which was removed during corrosion process. 
In general the vascular structure of cervical uterine leiomyomata resembled the 
composition of those tumors seen in myometrium of uterine corpus, but rather 
in very early stage of their development. Dense vascular capsule (pseudocapsule) 
is an important region of massive release of different pro- and antiangiogenic 
proteins which may promote changes in the periphery of the lesion [20, 27].
There have been a number of published studies using gene expression mi-
croarrays on leiomyoma tissue, used also gene expression microarray to identify 
angiogenesis-related genes with a differential expression between leiomyomata 
and adjacent myometrium [28–31], although in our case they seem to be out of 
use, since uterine cervix does not contain myometrial tissue. Anyway morpho-
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Fig. 1. Corrosion cast of uterine cervix of 39 year old female. SEM. Coronal section.  
Multiple intracervicalleiomomata. The marked area seen on the Fig. 2. Bar = 1000 μm.
Fig. 2. Corrosion cast of uterine cervix of 39 year old female. SEM. Intracervicalleiomomata [*]. 
Relatively dense “vascular capsule” []. Bar = 1000 μm.
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Fig. 3. Corrosion cast of uterine cervix of 45 year old female. SEM. Intracervicalleiomoma [*].  
Bar = 1000 μm.
Fig. 4. Corrosion cast of uterine cervix of 47 year old female. SEM. Coronal section.  
Loose “vascular capsule” of intracervical leiomyoma. Bar = 1000 μm.
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logical studies presented in this work seem to help to imagine how rich is the 
reservoir of connective tissue in the cervix (lack of tissue corroded), which may 
be very valuable source of proangiogenic factors, causing growth of leiomyomata 
[32, 33]. Further studies on the morphology may have a strong impact on me-
thods of pharmacological and surgical treatment [34].
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